PAX8 and thyroid cancer: Klhl14AS has already been described as ceRNA in thyroid cancer, where it acts as a decoy for miRNA182-5p and miRNA20a-5p, reducing their binding to the transcripts of both Pax8, a master regulator of thyroid differentiation, and Bcl2, a survival-promoting gene essential in thyroid physiology.